These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19563816)

  • 1. Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components.
    Martin H
    Mutat Res; 2009 Oct; 669(1-2):1-7. PubMed ID: 19563816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components.
    Martin H
    Mutat Res; 2010 Aug; 690(1-2):57-63. PubMed ID: 20973164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.
    Belvisi MG; Hele DJ; Birrell MA
    Eur J Pharmacol; 2006 Mar; 533(1-3):101-9. PubMed ID: 16458290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor gamma as a novel therapeutic target in asthma.
    Park SJ; Lee YC
    J Asthma; 2008; 45(1):1-8. PubMed ID: 18259989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock.
    Abdelrahman M; Sivarajah A; Thiemermann C
    Cardiovasc Res; 2005 Mar; 65(4):772-81. PubMed ID: 15721857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The many faces of PPARgamma: anti-inflammatory by any means?
    Szanto A; Nagy L
    Immunobiology; 2008; 213(9-10):789-803. PubMed ID: 18926294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARgamma as a new therapeutic target in inflammatory bowel diseases.
    Dubuquoy L; Rousseaux C; Thuru X; Peyrin-Biroulet L; Romano O; Chavatte P; Chamaillard M; Desreumaux P
    Gut; 2006 Sep; 55(9):1341-9. PubMed ID: 16905700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of the peroxisome proliferator-activated receptor gamma in the immune system of weaned pigs after Escherichia coli lipopolysaccharide injection.
    Liu Y; Lu J; Shi J; Hou Y; Zhu H; Zhao S; Liu H; Ding B; Yin Y; Yi G
    Vet Immunol Immunopathol; 2008 Jul; 124(1-2):82-92. PubMed ID: 18394717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary modulation of peroxisome proliferator-activated receptor gamma.
    Marion-Letellier R; Déchelotte P; Iacucci M; Ghosh S
    Gut; 2009 Apr; 58(4):586-93. PubMed ID: 19017686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPAR and Pain.
    Maeda T; Kishioka S
    Int Rev Neurobiol; 2009; 85():165-77. PubMed ID: 19607969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor gamma (PPAR gamma) and sepsis.
    von Knethen A; Soller M; Brüne B
    Arch Immunol Ther Exp (Warsz); 2007; 55(1):19-25. PubMed ID: 17277894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carnosic acid and carnosol, phenolic diterpene compounds of the labiate herbs rosemary and sage, are activators of the human peroxisome proliferator-activated receptor gamma.
    Rau O; Wurglics M; Paulke A; Zitzkowski J; Meindl N; Bock A; Dingermann T; Abdel-Tawab M; Schubert-Zsilavecz M
    Planta Med; 2006 Aug; 72(10):881-7. PubMed ID: 16858665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fluorescent indicator to visualize ligand-induced receptor/coactivator interactions for screening of peroxisome proliferator-activated receptor gamma ligands in living cells.
    Awais M; Sato M; Umezawa Y
    Biosens Bioelectron; 2007 May; 22(11):2564-9. PubMed ID: 17095203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular effects of PPARgamma activators - from bench to bedside.
    Marx N; Walcher D
    Prog Lipid Res; 2007 Nov; 46(6):283-96. PubMed ID: 17637478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 13-Oxo-ODE is an endogenous ligand for PPARgamma in human colonic epithelial cells.
    Altmann R; Hausmann M; Spöttl T; Gruber M; Bull AW; Menzel K; Vogl D; Herfarth H; Schölmerich J; Falk W; Rogler G
    Biochem Pharmacol; 2007 Aug; 74(4):612-22. PubMed ID: 17604003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fat poetry: a kingdom for PPAR gamma.
    Anghel SI; Wahli W
    Cell Res; 2007 Jun; 17(6):486-511. PubMed ID: 17563755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor gamma and its ligands in controlling interleukin-1beta target gene expression: a confusing story.
    François M; Richette P; Corvol MT
    Drug News Perspect; 2005 May; 18(4):257-61. PubMed ID: 16034482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [PPARgamma as a new therapeutic target in inflammatory diseases].
    Naito Y; Yoshikawa T
    Nihon Rinsho; 2010 Feb; 68(2):341-9. PubMed ID: 20158107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The many faces of PPARgamma.
    Lehrke M; Lazar MA
    Cell; 2005 Dec; 123(6):993-9. PubMed ID: 16360030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells.
    Bernardo A; Bianchi D; Magnaghi V; Minghetti L
    J Neuropathol Exp Neurol; 2009 Jul; 68(7):797-808. PubMed ID: 19535992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.